Dr. Rahul Anil Gaglani, MD

Dr. Gaglani practices at Inland Eye Specialists Surgery Center - Murrieta in Murrieta, California.

Dr. Gaglani's NPI, 1558692657, was assigned on January 29, 2010. Dr. Gaglani graduated from Ross University School of Medicine in 2006. Dr. Gaglani holds California license A138057.

Dr. Gaglani's primary practice is Inland Eye Specialists Surgery Center - Murrieta, at 25395 Hancock Avenue, Suite 100, Murrieta, CA 92562. The practice phone is (951) 696-5388.

Dr. Gaglani's primary practice is Inland Eye Specialists Surgery Center - Murrieta in Murrieta, California. Dr. Gaglani is also affiliated with Southwest Healthcare Rancho Springs Hospital. The medical group on file is Core Cardiology. Dmand AI also links Dr. Gaglani to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gaglani practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Gaglani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Gaglani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Gaglani's licenses on file in 2 states: California and New York.

Dmand AI lists angioplasty, cardiac catheterization, endocarditis and pacemaker or defibrillator implantation among the conditions Dr. Gaglani treats.

CMS data shows 2,014 Medicare services from Dr. Gaglani across 22 procedure codes in 2024, for 466 Medicare patients. Medicare paid $206,763 for them.

CMS counts 466 Medicare patients who saw Dr. Gaglani in 2024. The largest group is 65 to 74, with 220 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gaglani's median patient age at 66, with 53% women.

In 2024, Dr. Gaglani wrote 1,691 Medicare Part D claims for 259 patients. 80% of them were for generic drugs. CMS names the drug for 1,509 of them, across 23 drugs with 11 or more claims each, at $409,126 in total drug cost. In 2023, CMS named 1,600 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 13 out of 100 for Dr. Gaglani for performance year 2024, reported individually. Dr. Gaglani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gaglani as offering telehealth. CMS counts 30 procedures of coronary angioplasty and stenting by Dr. Gaglani, more than 66% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Gaglani. Dr. Gaglani's most frequent co-authors are John F. Heitner, MD, Terrence J. Sacchi, MD and Barry I. Saul, MD.

CMS Open Payments shows 534 general payments to Dr. Gaglani from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Boston Scientific Corporation paid the most, $2,976.

Dr. Gaglani graduated from Ross University School of Medicine in 2006. Dr. Gaglani is a member of ACC.

Dr. Gaglani is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.